ELAN vs LEN · rev $2.74B vs rev $34.19B
Elanco Animal Health (ELAN) versus LEN (LEN) — a side-by-side from cached financials, not a winner call.
Elanco Animal Health (ELAN) is a drug manufacturers - specialty & generic company listed on US.
LEN (LEN) common stock.
Latest reported ELAN revenue for 2026-06-30 was $2.74B. Net income was $111.0M. Revenue was up 99.8% from 2026-03-31 to 2026-06-30. ELAN currently screens at market cap $11.80B.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
ELAN currently screens at market cap $11.80B. LEN currently screens at market cap $0.
Not investment advice. Open the ELAN and LEN stock pages for the full models.
Not investment advice.